New treatment for old disease: Management of resistant hypertension by percutaneous renal sympathetic denervation;Un tratamiento nuevo para una enfermedad antigua: tratamiento de la hipertensión arterial resistente mediante denervación simpática renal percutánea

Revista Espanola de Cardiologia

Volumn 66, Issue 9, 2013, Pages 734-740

  Kanai, Takashi ^a   Krum, Henry ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Denervation; Renal sympathetic ablation; Resistant hypertension; Sympathetic nerve activity

Indexed keywords

ARTICLE; KIDNEY DENERVATION; RENAL SYMPATHETIC NERVE DENERVATION; RESISTANT HYPERTENSION; SYMPATHETIC NERVE; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; FEMALE; HUMAN; HYPERTENSION; INNERVATION; KIDNEY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SYMPATHECTOMY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SYMPATHECTOMY;

EID: 84881477486     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.06.002     Document Type: Article

References (24)

1. K. Wolf-Maier, R.S. Cooper, H. Kramer, J.R. Banegas, S. Giampaoli, and M.R. Joffres Hypertension treatment and control in five european countries, canada, and the united states Hypertension 43 2004 10 17 (Pubitemid 38031904)
2. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: Analysis of worldwide data Lancet 365 2005 217 223 (Pubitemid 40138015)
3. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913 (Pubitemid 35472129)
4. P.A. Sarafidis, and G.L. Bakris Resistant hypertension: an overview of evaluation and treatment J Am Coll Cardiol 52 2008 1749 1757
5. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
6. H. Krum, M. Schlaich, R. Whitbourn, P.A. Sobotka, J. Sadowski, and K. Bartus Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
7. Medtronic Inc. [consultado 6 Jun 2013]. Disponible en: http://www.medtronicrdn.com
8. Symplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months Hypertension 57 2011 911 917
9. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial Lancet 376 2010 1903 1909
10. M.D. Esler, H. Krum, M. Schlaich, R.E. Schmieder, M. Bohm, and P.A. Sobotka Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial Circulation 126 2012 2976 2982
11. M.P. Schlaich, P.A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M.D. Esler Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept Hypertension 54 2009 1195 1201
12. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 2009 932 934
13. H. Krum, P. Sobotka, F. Mahfoud, M. Bohm, M. Esler, and M. Schlaich Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system Circulation 123 2011 209 215
14. S. Julius, and K. Jamerson Sympathetics, insulin resistance and coronary risk in hypertension: The 'chicken-and-egg' question J Hypertens 12 1994 495 502 (Pubitemid 24192873)
15. H. Kumagai, N. Oshima, T. Matsuura, K. Iigaya, M. Imai, and H. Onimaru Importance of rostral ventrolateral medulla neurons in determining efferent sympathetic nerve activity and blood pressure Hypertens Res 35 2012 132 141
16. M.P. Schlaich, F. Socratous, S. Hennebry, N. Eikelis, E.A. Lambert, and N. Straznicky Sympathetic activation in chronic renal failure J Am Soc Nephrol 20 2009 933 939
17. S. Ye, H. Zhong, V. Yanamadala, and V.M. Campese Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity Am J Hypertens 15 2002 717 724 (Pubitemid 34804278)
18. S. Ye, B. Ozgur, and V.M. Campese Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure Kidney Int 51 1997 722 727 (Pubitemid 27157956)
19. G. Mancia, P. Bousquet, J.L. Elghozi, M. Esler, G. Grassi, and S. Julius The sympathetic nervous system and the metabolic syndrome J Hypertens 25 2007 909 920 (Pubitemid 46573105)
20. F. Mahfoud, M. Schlaich, I. Kindermann, C. Ukena, B. Cremers, and M.C. Brandt Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study Circulation 123 2011 1940 1946
21. D.E. Kandzari, D.L. Bhatt, P.A. Sobotka, W.W. O'Neill, M. Esler, and J.M. Flack Catheter-based renal denervation for resistant hypertension: Rationale and design of the symplicity htn-3 trial Clin Cardiol 35 2012 528 535
22. C. Templin, M. Jaguszewski, J.R. Ghadri, I. Sudano, R. Gaehwiler, and J.P. Hellermann Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Symplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter Eur Heart J 2013 10.1093/eurheartj/eht141
23. J.A. Ormiston, T. Watson, N. Van Pelt, R. Stewart, J.T. Stewart, and J.M. White Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial EuroIntervention 9 2013 70 74
24. T. Mabin, M. Sapoval, V. Cabane, J. Stemmett, and M. Iyer First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension EuroIntervention 8 2012 57 61